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Abstract
Objective: To examine the validity and reliability of a Japanese version of the Symptom Checklist
90 Revised (SCL-90-R (J)).
Methods: The English SCL-90-R was translated to Japanese and the Japanese version confirmed
by back-translation. To determine the factor validity and internal consistency of the nine primary
subscales, 460 people from the community completed SCL-90-R(J). Test-retest reliability was
examined for 104 outpatients and 124 healthy undergraduate students. The convergent-
discriminant validity was determined for 80 inpatients who replied to both SCL-90-R(J) and the
Minnesota Multiphasic Personality Inventory (MMPI).
Results: The correlation coefficients between the nine primary subscales and items were .26 to
.78. Cronbach's alpha coefficients were from .76 (Phobic Anxiety) to .86 (Interpersonal Sensitivity).
Pearson's correlation coefficients between test-retest scores were from .81 (Psychoticism) to .90
(Somatization) for the outpatients and were from .64 (Phobic Anxiety) to .78 (Paranoid Ideation)
for the students. Each of the nine primary subscales correlated well with their corresponding
constructs in the MMPI.
Conclusion: We confirmed the validity and reliability of SCL-90-R(J) for the measurement of
individual distress. The nine primary subscales were consistent with the items of the original English
version.
Background
The Symptom Checklist 90 Revised (SCL-90-R) developed
by L.R. Derogatis [1] has been widely used as a clinical
assessment and research tool in many countries and is
cited in many articles. The scale can assess nine primary
psychological symptoms as follows: Somatization (SOM),
Obsessive-Compulsive (O-C), Interpersonal Sensitivity
(INT), Depression (DEP), Anxiety (ANX), Hostility
(HOS), Phobic Anxiety (PHOB), Paranoid Ideation
(PAR), and Psychoticism (PSY).
Although this scale was developed in the late 1970's [2,3],
it can still be helpful for understanding psychiatric dis-
eases as classified in the latest version of the diagnostic cri-
teria of DSM-IV[4] and ICD-10 [5].
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Many studies have reported that a patient presenting one
functional somatic disorder also has symptoms related to
psychiatric disorders. For example, Juang et al. [6]
reported comorbidity of depressive and anxiety disorders
in chronic headache. Seventy-eight percent of patients
with migraine had psychiatric comorbidity, including
major depression (57%), dysthymia (11%), panic disor-
der (30%), and generalized anxiety disorder (8%). Sixty
four percent of patients with chronic tension-type head-
ache had psychiatric comorbidity, including major
depression (51%), dysthymia (8%), and panic disorder
(22%). Comorbidity of major depression and panic disor-
der has often been reported [7,8].
It has been shown that some medicines are effective
against multiple psychiatric diseases. For example, selec-
tive serotonin reuptake inhibitors (SSRI) are antidepres-
sants that can also be effective against obsessive-
compulsive disorder [9], panic disorder [10] and social
anxiety disorder [11].
Multi-dimensional assessment tools for psychiatric condi-
tions are needed for the diagnosis of patients in psychoso-
matic or psychiatric settings.
The only inventory that includes most aspects of emo-
tional disturbances within a comprehensive classification
of psychiatric diseases in Japan is the Minnesota Mul-
tiphasic Personality Inventory (MMPI)[12]. However, this
scale can become a considerable burden to patients
because there are a great many questions. More compact
scales for measuring multiple psychiatric dimensions are
needed.
In this paper we report the development of a Japanese ver-
sion of SCL-90-R (SCL-90-R(J)). In study 1 the original
English version of the SCL-90-R was translated into Japa-
nese and factorial validity and internal consistency were
calculated to confirm reliability. Study 2 was done to
determine the test-retest reliability of the SCL-90-R(J) by
testing psychosomatic medicine outpatients and healthy
persons. The aim of study 3 was to investigate the relation-
ship between SCL-90-R(J) and existing scales currently
used to measure psychological symptoms in Japan. This
investigation was done to show the convergent-discrimi-
nant validity of the primary nine subscales of SCL-90-R(J).
Methods
Subjects
The SCL-90-R(J) was distributed to 1,200 people living in
the suburbs of Fukuoka City who reported for a free med-
ical examination given by the municipal government. The
completed forms were returned by mail. Available for
analysis were 460 complete forms of 507 (42%) residents
who replied (143 men, average age 59.6 years, and 317
women, average age 50.9 years) in study 1.
118 patients visiting the Department of Psychosomatic
Medicine at Kyushu University Hospital who gave
informed consent to the study and were given guarantees
of protection of private data in the possession their doc-
tor. The SCL-90-R(J) was administered at one visit, and a
retest was administrated at the next visit. Available for
analysis were 104 inventories completed within 35 days
(34 men, average age 39.4 years, and 70 women, average
age 40.0 years) in study 2. As for the primary diseases of
104 patients, 70.2% were mental diseases and 29.8% were
physical diseases. When classified by the mental diseases
mentioned in the patients' medical record, 40.4% were
diseases related to depression, including diagnosis of
depression, neurotic depression, dysthymic disorder.
22.1% were diseases related to anxiety, including anxiety
disorder, panic disorder, posttraumatic stress disorder
(PTSD), and anxiety neurosis. 4.8% were somatoform dis-
orders, including pain disorder, body dysmorphic disor-
der and psychogenic aphonia. Two patients had eating
disorders and one patient had sleep disorder. As for phys-
ical diseases, 13.5% were vegetative syndrome, 6.7% were
irritable bowel syndrome, and 2.9% were bronchial
asthma. Atopic dermatitis and hyperventilation syndrome
were 1.9% each. Functional dyspepsia, hypertendion and
combined headache were suffered by one patient each.
In study 2, also analyzed were the SCL-90-R(J) test/retest
results of 124 healthy undergraduate students (28 men,
average age 19.3 years, and 96 women, average age 19.1
years) who attended a psychological guidance lecture at a
university in Fukuoka prefecture. The period between test
and retest was a week.
Eighty-seven inpatients at Kyushu University Hospital
Department of Psychosomatic Medicine replied to the
SCL-90-R(J). Of these patients, the results of 80 who
replied to both the SCL-90-R(J) and MMPI were analyzed
in study 3 (26 males, mean age 37.8 years (SD = 11.7),
and 54 females, mean age 33.0 years (SD = 16.1)). Five of
eighty patients were overlapped with outpatients who
were employed for test/retest examination. As for the pri-
mary diseases of 80 patients, 70% were mental diseases
and 30% were physical diseases. As classified by DSM-IV,
26.3% were depressive disorders, 21.3% were eating dis-
orders, 11.3% were anxiety disorders, 5.0% were somato-
form disorders, 3.8% were adjustment disorders and 2.5%
were sleep disorders. As for physical diseases, 16.3% (N =
13) were diabetes mellitus (DM). Ten diabetics were Type
1 DM, and all patients had eating disorders. 3.8% had
bronchial asthma and 2.5% had irritable bowel syn-
drome. Atopic dermatitis, lactose intolerance, cough vari-
ant asthma, Crohn's disease, spasmodic torticollis, andBioPsychoSocial Medicine 2008, 2:19 http://www.bpsmedicine.com/content/2/1/19
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chronic fatigue syndrome were experienced by one patient
each.
SCL-90-R(J)
Permission was obtained from the copyright holder to
translate the original version of SCL-90-R to Japanese. The
translation to Japanese was done by two psychologists.
The Japanese version was then back-translated to check
for correspondence with the English version. The
respondents were asked to describe how much each of 90
problems had distressed or bothered them in the past
seven days, including that day. The descriptors were as fol-
lows: not at all (0), a little bit (1), moderately (2), quite a
bit (3), extremely (4).
MMPI
The MMPI is often used in Japan to assess the psycholog-
ical state and is commonly used in other countries. Stud-
ies of the reliability and validity of this scale have been
reported in many articles. To validate the SCL-90-R(J), not
only the 10 standard clinical scales (C), but also Wiggins
[13] content scales (W) and Tryon's [14] cluster scales (T)
were scored.
Data analysis
The Statistical Analysis System (SAS) was used for data
analysis. In study 1, confirmative factor analysis was done
by the Calis Procedure for covariance structure analysis.
Cronbach's alpha coefficients were calculated by Corr Pro-
cedure to examine the internal consistencies of each of the
nine subscales. In study 2, Pearson's correlation coeffi-
cients between the first and second test administrations
were calculated using the Corr Procedure to examine the
test-retest reliability. In study 3, Pearson's correlation
coefficients between subscale scores of SCL-90-R(J) and
MMPI scores were calculated.
Results
Factorial validity and internal consistency (Study 1)
The results of confirmative factor analysis are shown in
Figure 1. The analysis was done for each of the nine fac-
tors. All values of the goodness of fit index (GFI) and
adjusted GFI for the nine primary symptoms were over
.90. Except for two items on SOM and two items on DEP,
the correlation coefficients between each factor and item
were over .35.
Cronbach's alpha coefficients were .76 (PHOB) to .86
(INT)(Table 1).
Test/retest reliability (Study 2)
Correlations between test and retest were calculated for
outpatients and students (Table 2). Pearson's correlation
coefficients were .81 (PSY) to .90 (SOM) for the outpa-
tients and .64 (PHOB) to .78 (PAR) for the student group.
Convergent-discriminant validation (Study 3)
Pearson's product-moment correlation coefficients were
calculated between the nine primary subscales of SCL-90-
R(J) and the multidimensional subscale of MMPI (Table
2).
The SOM scale showed high correlations with Body Symp-
toms (T) and Hypochondriasis (C). The SOM scale
showed correlation coefficients lower than 0.20 (p > .05)
with Masculinity-Femininity (C), Social Introversion (C),
Social Maladjustment (W), Feminine Interest (W) and
Religious Fundamentalism (W).
The O-C scale showed high correlations with Pshchasthe-
nia (C), Tension (T), and Autism (T). The O-C scale
showed correlation coefficients lower than 0.20 (p > .05)
with Hysteria (C), Masculinity-Femininity (C) and Femi-
nine Interest (W).
The INT scale showed high correlations with Poor Morale
(W), Psychasthenia (C), and Depression (W, T). The INT
scale showed correlation coefficients lower than 0.20 (p >
.05) with Hysteria (C), Masculinity-Femininity (C), Fem-
inine Interest (W) and Religious Fundamentalism (W).
The DEP scale showed high correlations with Psychasthe-
nia (C), Depression (W, T), and Tension (T). The DEP
scale showed correlation coefficients lower than 0.20 (p >
.05) with Hysteria (C), Masculinity-Femininity (C), Social
Maladjustment, Feminine Interest (W) and Religious Fun-
damentalism (W).
The ANX scale showed high correlations with Tension (T),
Psychasthenia (C), and Phobia (W). The ANX scale
showed correlation coefficients lower than 0.20 (p > .05)
with Masculinity-Femininity (C), Feminine Interest (W)
and Religious Fundamentalism (W).
The HOS scale showed high correlations with Manifest
Hostility (W), Suspicion and Mistrust (T), and Resent-
ment and Aggression (T). The HOS scale showed correla-
tion coefficients lower than 0.20 (p > .05) with Hysteria
(C), Masculinity-Femininity (C), Feminine Interest (W)
and Religious Fundamentalism (W).
The PHOB scale showed high correlations with Psychoti-
cism (W), Tension (T), and Phobias (W). The PHOB scale
showed correlation coefficients lower than 0.20 (p > .05)
with Hysteria (C), Masculinity-Femininity (C), Social
Introversion (C, T), Social Maladjustment (W), Feminine
Interest (W), Religious Fundamentalism (W) and Family
Problems (W).
The PAR scale showed high correlations with Psychoti-
cism (W), Schizophrenia (C), and Suspicion and MistrustBioPsychoSocial Medicine 2008, 2:19 http://www.bpsmedicine.com/content/2/1/19
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(T). The PAR scale showed correlation coefficients lower
than 0.20 (p > .05) with Depression (C), Hysteria (C),
Masculinity-Femininity (C) and Feminine Interest (W).
The PSY scale showed high correlations with Psychoticism
(W), Suspicion and Mistrust (T), and Schizophrenia (C).
The PSY scale showed correlation coefficients lower than
0.20 (p > .05) with Depression (C), Hysteria (C), Mascu-
linity-Femininity (C), Social Maladjustment (W), Femi-
nine Interest (W) and Religious Fundamentalism (W).
Gender differences
The scores of the nine subscales for all subjects of this
study are displayed in Table 3. Gender differences are also
examined in this table. In the community sample, gender
differences were found in O-C (t(458) = 2.32, p = .020)
and PSY (t(241) = 2.58, p = .010). In the student sample,
gender difference was found in PAR (t(122) = 2.08, p =
.040). For outpatients, gender differences were found in
SOM (t(102) = 2.35, p = .020), O-C (t(102) = 2.09, p =
.039), HOS (t(95.6) = 2.53, p = .013) and PAR (t(102) =
2.24, p = .027). For inpatients, no gender difference was
found among the nine subscales.
Confirmative factor analysis of the nine primary symptom constructs of SCL-90-R(J)1) Figure 1
Confirmative factor analysis of the nine primary symptom constructs of SCL-90-R(J). Numbers in boxes accord 
with the item number of SCL-90-R(J), please see references [1] and [3]. *Goodness of Fit Index(GFI), **Adjusted GFI(AGFI).
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Discussion
The validity and reliability of SCL-90-R(J)
We examined the validity and reliability of SCL-90-R(J)
for use as a psychometric scale.
SCL-90-R(J) was consistent with the nine primary scales of
the original version (Study 1). The data showed that each
subscale consisted of items similar enough to the English
version that each scale had sufficient internal consistency,
indicating its reliability for psychometric testing.
Test-retest reliability was sufficient for the outpatient
group. The student group indicated moderate but lower
reliability coefficients than the outpatient group (Study
2). The students may have responded according to their
mood at the time they filled out the questionnaire rather
than to their symptoms, while the patients responded to
their symptoms. Because the retest was done by the stu-
dents at a shorter interval than the patients, the results for
the students were of higher reliability than those of the
patients. The results were the reverse to our expectations,
suggesting that this scale will show a superior perform-
ance when used for patients than for healthy persons such
as students.
Convergent-discriminant validation demonstrates that
measures of interest show strong correlations with inde-
pendent measures of the same construct and show weak
or no correlation with measures of dissimilar constructs.
The primary nine subscales of SCL-90-R(J) were strongly
correlated with the MMPI subscales of the same or similar
construct (Study 3). In addition, dissimilar subscales of
MMPI had lower correlation with the SCL-90-R(J) sub-
scales. These results also suggest that the SCL-90-R(J) has
convergent and discriminant validity and that the scale is
able to assess the constructs that it is intended to measure.
Because we translated the English checklist into Japanese,
it was possible that an individual item had a weak rela-
tionship with the subscale in the original version. First, we
examined whether or not the nine primary scales of the
Japanese version consisted of items the same as the origi-
nal version (study 1). Confirmative factor analysis
showed that almost all items highly correlated with each
factor (symptoms) contained in the items in the original
version. The data showed that our nine subscales of the
Japanese version consisted of the same items as in the
English original version. Confirmative factor analysis also
demonstrated that each factor had high validation.
Research that would benefit from the use of SCL-90-R(J)
includes comparative cross-cultural studies. Several stud-
ies have been published that have compared the psycho-
pathology between countries using the SCL-90-R [15,16].
These studies need to be consistent in their use of the
same scale from the same items. Our version has this nec-
essary condition with good validation.
Convergent-discriminant validation was demonstrated by
contrasting the subscale scores of SCL-90-R(J) with scores
from the MMPI. As summarized in Table 2, nine subscales
were consistent with the corresponding scales from
MMPI. The tendency of the correlation coefficients was
similar to the data of Derogatis et al. [17]. In their article,
they reported that O-C was not well correlated with MMPI
constructs because there was no directly comparable scale
on the MMPI. Although this was not changed essentially
in our design, the O-C subscale had a moderate relation-
ship with the subscale from MMPI, which would explain
the clinical symptoms of obsessive-compulsive disorder
in our results.
SCL-90-R is a good tool for researching individual psycho-
logical distress. Because this psychological scale can eval-
uate multidimensional psychopathological aspects
simultaneously, it is effective as a screening test for medi-
cal examination and treatment. It is also effective for an
effect judgment of drug efficacy, such as SSRI against anx-
Table 1: Internal consistency and test-retest reliability coefficients of SCL-90-R(J)
Internal Consistency (coefficient ) Test-Retest (Pearson's r)
Community N = 460 Outpatients N = 104 Students N = 124
Somatization .81 .90* .73*
Obsessive-Compulsive .85 .85* .74*
Inter person al Sensitivity .86 .88* .76*
Depression .85 .86* .76*
Anxiety .79 .88* .73*
Hostility .79 .82* .67*
Phobic Anxiety .76 .88* .64*
Paranoid Ideation .79 .83* .78*
Psychoticism .83 .81* .75*
*P < .0001BioPsychoSocial Medicine 2008, 2:19 http://www.bpsmedicine.com/content/2/1/19
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Table 2: Correlations between SCL-90-R(J) primary symptom dimensions and MMPI Clinical(C), Wiggin s(W), and Tryon-Stein-Chu 
(T) scales
Symptom Correlation1) Symptom Correlation1)
Somatization Phobia (W) .63*
Body Symptoms (T) .74* Schizophrenia (C) .60*
Hypochondriasis (C) .70* Psychoticism (W) .60*
Organic Symptoms (W) .70* Autism (T) .58*
Poor Health (W) .56* Depression (W) .57*
Organic Symptoms (W) .56*
Obsessive-Compulsive Poor Morale (W) .54*
Psychasthenia(C) .68* Depression (T) .52*
Tension (T) .68* Hypochondriasis (C) .51*
Autism (T) .67*
Schizophrenia (C) .65* Hostility
Depression (W) .61* Manifest Hostility (W) .67*
Poor Morale (W) .61* Suspicion & Mistrust (T) .61*
Psychoticism (W) .60* Resentment & Aggression (T) .59*
Organic Symptoms ((W) .60* Depression (W) .57*
Body Symptoms (T) .57* Psychoticism (W) .57*
Phobias (W) .56* Tension (T) .57*
Depression (T) .56* Schizophrenia (C) .55*
Resentment & Aggression (T) .55* Depression (T) .55*
Hypochondriasis (C) .52* Poor Morale (W) .54*
Manifest Hostility (W) .51* Psychasthenia (C) .53*
Hypomania (W) .51*
Phobic Anxiety
Interpersonal Sensitivity Psychoticism (W) .57*
Poor Morale (W) .72* Tension (T) .55*
Psychasthenia(C) .70* Phobias (W) .52*
Depression (W) .68* Depression (W) .51*
Depression (T) .68* Schizophrenia (C) .50*
Psychoticism (W) .65* Suspicion & Mistrust (T) .50*
Suspicion & Mistrust (T) .65*
Schizophrenia (C) .64* Paranoid Ideation
Tension (T) .63* Psychoticism (W) .62*
Autism (T) .62* Schizophrenia (C) .61*
Manifest Hostility (W) .59* Suspicion & Mistrust (T) .61*
Resentment & Aggression (T) .58* Autism (T) .59*
Phobias (W) .54* Psychasthenia (C) .57*
Depression (W) .56*
Depression Poor Morale (W) .56*
Psychasthenia (C) .78* Manifest Hostility (W) .53*
Depression (W) .76* Depression (T) .53*
Depression (T) .71* Resentment & Aggression (T) .52*
Tension (T) .71* Authority Conflict (W) .51*
Schizophrenia (C) .70* Tension (T) .51*
Poor Morale (W) .70* Hypomania (W) .50*
Autism (T) .64*
Psychoticism (W) .62* Psychoticism
Resentment & Aggression (T) .60* Psychoticism (W) .69*
Phobias (W) .59* Suspicion & Mistrust (T) .67*
Body Symptoms (T) .58* Schizophrenia (C) .66*
Organic Symptoms (W) .54* Autism (T) .65*
Manifest Hostility (W) .54* Psychasthenia (C) .64*
Suspicion & Mistrust (T) .54* Depression (W) .64*
Hypochondriasis (C) .52* Manifest Hostility (W) .61*
Paranoia (C) .51* Tension (T) .59*
Psychopathic Deviate (C) .50* Poor Morale (W) .58*
Resentment & Aggression (T) .58*
Anxiety Depression (T) .55*
Tension (T) .71* Hypomania (W) .51*
Psychasthenia (C) .66* Hypomania (C) .50*
1) Displayed correlation coefficient was .50 or more. N = 80. *p < 0.0001BioPsychoSocial Medicine 2008, 2:19 http://www.bpsmedicine.com/content/2/1/19
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iety symptoms [10,11] as well as a depressive mood
[18,19]. For example, co-morbidity of major depression
and panic disorder has often been reported [7,8], which
indicates that SCL-90-R(J) is suitable for the evaluation of
patients having such plural diseases. This scale would also
be useful for researching the correlation between physical
diseases and psychological dysfunction. Mikocka-Walus
et al. [20] used this scale to examine the relationship
between mental distress and relapse in patients with dis-
eases of the digestive tract.
Gender differences
Gender differences in SCL-90-R have been reported [21-
24]. Previous articles reported that there was a tendency
toward higher scores for females than males on the nine
subscales. Most of the gender differences on the nine sub-
scales were statistically significant. The trend was particu-
larly notable for the outpatient sample of this study. But,
the gender differences in this study were small when com-
pared with previous studies. There were no significant dif-
ferences in any of the subscales in the inpatient sample.
Though this may be characteristic of Japan, further
research to examine a larger sample and data from many
institutions will be necessary.
Limitations of this study
This study has several limitations. We did not gather the
data of psychiatric patients in this study. Data collection
for a group of psychiatric patients will be necessary in
future study. When a cut-off point is set, utility is high for
clinical application.
Also, our data was collected in only one area of Japan. This
might include the possibility of local bias. Future research
will include comparative studies of the data from several
Japanese areas.
Conclusion
We examined the validity and reliability of SCL-90-R(J).
Almost of all of the correlation coefficients between the
nine primary subscales and items were over .35. Cron-
bach's alpha coefficients were from .76 (Phobic Anxiety)
to .86 (Interpersonal Sensitivity). Pearson's correlation
coefficients between test-retest scores were from .81 (Psy-
choticism) to .90 (Somatization) for the outpatients and
were from .64 (Phobic Anxiety) to .78 (Paranoid Idea-
tion) for the students. Each of the nine primary subscales
correlated well with their corresponding constructs in the
MMPI. We confirmed the validity and reliability of SCL-
90-R(J) for the measurement of individual distress.
Because the nine primary subscales were consistent with
the items of the original English version, this SCL-90-R(J)
will be useful for comparative cross-culture study. Also,
this psychological scale can evaluate multidimensional
psychopathological aspects simultaneously, which makes
it useful as a screening test for medical examination and
Table 3: The basic data and gender differences of the nine primary scales for community, student, out patient, and inpatient samples1)
SOM O-C INT DEP ANX HOS PHOB PAR PSY
Community samples
All (N = 460) .63 (.48) .72 (.56) .56 (.52) .73 (.53) .38 (.39) .47 (.50) .16 (.30) .52 (.53) .28 (.38)
Men (N = 143) .64 (.50) .81 (.59) .54 (.49) .75 (.49) .43 (.41) .52 (.50) .16 (.32) .59 (.55) .36 (.42)
Women (N = 317) .63 (.47) .68 (.55) .58 (.54) .73 (.55) .36 (.38) .45 (.51) .16 (.29) .49 (.52) .25 (.36)
P2) n  s. 0 2 0 n  sn  sn  sn  s n  s n  s. 0 1 0
Undergraduate students
All (N = 124) .71 (.58) .99 (.63) .82 (.68) .95 (.69) .68 (.62) .74 (.68) .30 (.45) .65 (.68) .40 (.53)
Men (N = 28) .66 (.47) .91 (.59) .84 (.67) .88 (.67) .54 (.48) .78 (.67) .27 (.43) .88 (.75) .46 (.57)
Women (N = 96) .73 (.61) 1.02 (.64) .82 (.69) .97 (.70) .72 (.65) .72 (.69) .31 (.46) .58 (.64) .38 (.52)
P2) ns ns ns ns ns ns ns .040 ns
Outpatients
All (N = 104) 1.14 (.86) 1.28 (.91) 1.13 (.90) 1.45 (.93) 1.04 (.88) .85 (.80) .75 (.85) .92 (.85) .65 (.63)
Men (N = 34) .86 (.74) 1.02 (.87) .89 (.92) 1.19 (.95) 0.84 (.79) .61 (.55) .57 (.81) .66 (.75) .51 (.61)
Women (N = 70) 1.27 (.89) 1.41 (.90) 1.25 (.87) 1.57 (.91) 1.14 (.90) .97 (.88) .83 (.87) 1.05 (.87) .72 (.63)
P2) .020 .039 n s n s n s .013 n s .027 n s
Inpatients
All (N = 80) 1.05 (.75) 1.29 (.94) 1.14 (.89) 1.60 (.96) 1.03 (.92) .79 (.92) .69 (.77) .94 (.92) .86 (.82)
Men (N = 26) 1.07 (.73) 1.28 (.94) 1.13 (.92) 1.54 (.92) 1.03 (.87) .87 (.94) .71 (.68) 1.04 (.95) .83 (.89)
Women (N = 54) 1.04 (.76) 1.30 (.95) 1.14 (.89) 1.63 (.99) 1.03 (.95) .75 (.91) .68 (.82) .90 (.91) .88 (.80)
P2) n  sn  sn  sn  sn  sn  s n  s n  sn  s
SOM:Somatization, O-C: Obsessive-Compulsive, INT: Interpersonal Sensitivity, DEP: Depression, ANX: Anxiety, HOS: Hostility, PHOB: Phobic 
Anxiety, PAR: Paranoid Ideation, PSY: Psychoticism.
1) Means (SD)
2)The results of t-test on gender differences (men vs women). ns: none significancePublish with BioMed Central    and   every 
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treatment. For example, it will be useful for judging drug
efficacy, such as SSRI for anxiety and depression.
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